CD34 and acute myeloid leukemia: The results of our two approaches indicate that AFM28 can induce the depletion of CD123+ LSPCs and blasts via NK cells in CD34+ samples of patients with AML and HR-MDS, resulting in fewer formed colonies, corroborating that LSPCs were indeed reduced.